Table of Contents Table of Contents
Previous Page  630 656 Next Page
Information
Show Menu
Previous Page 630 656 Next Page
Page Background

considering bacteria, which may travel via the ascending

urethral route. However, it must be recognized that bacteria

may be able to localize in the most favorable ecological

niche of an organ also irrespectively of the entry route.

Having said that, in order to reduce potential biases

inherent to differences among prostate zones, we consid-

ered only specimens from the peripheral zone of the

prostate where the tumor preferentially occurs.

Our study is not devoid of limitations. First, it is not

possible to control for bacteria possibly introduced as part

of the transrectal biopsy procedure. Although remote, since

the composition of the colon microbiome is completely

different, this would remain a limit also in potential

prospective studies due to the difficulty to obtain consent

for extra biopsies to be devoted to research from diagnostic

sampling.

Within each tumor specimen, the area with the highest-

grade tumor has been sampled. In order to correctly

interpret the present findings, it must be recognized that

this choice does not allow to discern intra-specimen

differences in microbiome between high and low grade

diseases. As for the interspecimen differences, no correla-

tion with the grade, as well as the stage of the disease and

the findings reported were observed. This lack of correlation

may be also due to the limited number of cases; thereof, it

does not rule out the possibility that the tumor grade may

be associated to a different microbiome microenvironment.

As a consequence, studies on a wider number of cases,

stratified according to the stage and grade, will be necessary

to clarify this issue.

Being aware of the limit inherent in performing

statistical analysis only on 16 cases, we consider these

results of clinical relevance since they depict the microbial

microenvironment of the tumoral prostate gland, which is

per se an interesting and novel finding as it offers the

opportunity to consider the disease and its future manage-

ment from a different perspective.

Major strength of this analysis was the novel detailed

description of the microbiome environment specifically

associated to the tumor lesion and its surrounding areas,

thus highlighting the relevance the prostate prokaryotes

may have in the evolution of this disease. This keeps its

potential prospective importance despite having been

almost obliged to use only a relatively small amount of

samples, which could have possibly resulted in an

underestimation of our findings in terms of differences in

microbial diversity and accuracy in relative abundance.

Future studies are necessary to clarify the possible

pathogenic role of these specific bacteria and to assess their

potential to be exploited as new biomarkers.

5.

Conclusions

This ultradeep pyrosequencing approach provided novel

findings of a large population of bacteria within the

prostate, never detected before using traditional standard

culture-based methods. Moreover, because of the ability to

analyze tissue environments with very low bacterial load,

we detected less abundant species below the previous

detectability; these observations pointed out subtle differ-

ences between a tumoral lesion and its surrounding tissues.

Overall, we consider these findings of crucial translational

relevance since they pave the way for future investigations

aimed to discover whether the specific prokaryotic inha-

bitants of the PCa microenvironment and/or their metab-

olites can be exploited as novel biomarkers and/or

therapeutic targets.

Author contributions:

Filippo Canducci had full access to all the data in

the study and takes responsibility for the integrity of the data and the

accuracy of the data analysis.

Study concept and design:

Canducci, Cavarretta, Salonia, Briganti.

Acquisition of data:

Ferrarese, Saita, Lavorgna, Ceresola.

Analysis and interpretation of data:

Cavarretta, Ferrarese, Cazzaniga,

Nebuloni.

Drafting of the manuscript:

Cavarretta, Cazzaniga.

Critical revision of the manuscript for important intellectual content:

Salonia, Canducci, Cavarretta.

Statistical analysis:

Ferrarese, Canducci.

Obtaining funding:

None.

Administrative, technical, or material support:

Locatelli, Doglioni, Visconti.

Supervision:

Salonia, Montorsi, Clementi.

Other

(sample collection and processing)

:

Locatelli, Luciano` .

Financial disclosures:

Filippo Canducci certifies that all conflicts of

interest, including specific financial interests and relationships and

affiliations relevant to the subject matter or materials discussed in the

manuscript (eg, employment/affiliation, grants or funding, consultan-

cies, honoraria, stock ownership or options, expert testimony, royalties,

or patents filed, received, or pending), are the following: None.

Funding/Support and role of the sponsor:

None.

Acknowledgments:

The authors thank Olivia Morrow for reviewing

the language and Eugenio Ventimiglia for reviewing the statistical

analyses.

Appendix A. Supplementary data

Supplementary data associated with this article can be

found, in the online version, at

http://dx.doi.org/10.1016/ j.eururo.2017.03.029 .

References

[1]

Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol 2016;27:725–31.

[2]

Sfanos KS, Isaacs WB, De Marzo AM. Infections and inflammation in prostate cancer. Am J Clin Exp Urol 2013;1:3–11.

[3]

De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256–69.

[4]

Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol 2017;35:867–74.

[5]

Hullar MA, Burnett-Hartman AN, Lampe JW. Gut microbes, diet, and cancer. Cancer Treat Res 2014;159:377–99

.

[6]

Holmes E, Li JV, Athanasiou T, Ashrafian H, Nicholson JK. Under- standing the role of gut microbiome-host metabolic signal disrup- tion in health and disease. Trends Microbiol 2011;19:349–59.

[7]

Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–7.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 2 5 – 6 3 1

630